News
Tick-borne encephalitis found in England
23 November 2023
A new health report published by the UK Government says Tick-borne encephalitis virus (TBEV) has now been detected in multiple places across England since 2019. A joint report by the UKHSA and DEFRA said there have been 3 cases of probable or confirmed tick-borne encephalitis acquired in England since 2019, including one linked to the Yorkshire area in […]
Read More
Encephalitis International's royal appointment
23 November 2023
Encephalitis International was invited to meet King Charles III during his surprise visit to our home town on Wednesday. His Royal Highness spoke to representatives from several charities from Malton in North Yorkshire. Phillippa Chapman, our Deputy Chief Executive, and Trustee Adele Mackinlay, were given the honour of representing the Encephalitis International on Wednesday (April […]
Read More
Cure One, Cure Many - $10M program launched
22 November 2023
Encephalitis International has teamed up with the American Brain Foundation on an important new drive to investigate neuroinflammation and the brain. The $10 million cross-disciplinary research initiative transcends traditional research and philanthropy boundaries by bringing together non profit organizations, pharmaceutical and biotech investors, philanthropists, and researchers. The initiative will provide funding for research by top […]
Read More
Natalie's legacy
21 November 2023
Forty years ago, I came down with violent headaches. I couldn’t bear light or noise and I struggled to stay awake (writes Natalie). The first GP we saw said it was a virus and that I would be running around in a week. I wasn’t. We saw a different GP who referred me to a […]
Read More
Enceph-IG Trial - care centres needed
12 September 2023
Enceph-IG Trial: Intravenous Immunoglobulin (IVIG) in Autoimmune Encephalitis in Adults –A Randomised Double-Blind Placebo-Controlled Trial Can you help? Researchers are seeking secondary or tertiary care centres to help a trial establish whether with intravenous immunoglobulin improves recovery in adults with autoimmune encephalitis. Enceph-IG is a phase III, double blind, randomised placebo control trial lead by […]
Read More